Literature DB >> 17278680

The changing age distribution of prostate cancer in Canada.

C Ineke Neutel1, Ru-Nie Gao, Paul A Blood, Leslie A Gaudette.   

Abstract

BACKGROUND: Prostate cancer incidence rates are still increasing steadily; mortality rates are levelling, possibly decreasing; and hospitalization rates for many diagnoses are decreasing. Our objective is to examine changes in age distributions of prostate cancer during these times of change.
METHODS: Prostate cancer cases were derived from the Canadian Cancer Registry, prostate cancer deaths from Vital Statistics, hospitalizations from the Hospital Morbidity File. Age-standardized rates were calculated based on the 1991 Canadian population. A prevalence correction for incidence rates was calculated.
RESULTS: Age-specific incidence rates increased until 1995 for all ages, but a superimposed peak (1991-94) was greatest between ages 60-79. After 1995, increases in incidence continued for the under-70 age groups. Prevalence correction indicated the greatest underestimation of incidence rates for the oldest ages, but was less in Canada than in the United States. Mortality rates increased until 1994, then levelled and slowly decreased; age-specific mortality rates showed the greatest increase for the oldest ages but the earliest downturn for younger age groups. While hospitalizations dropped drastically after 1991, this drop was confined to elderly men (70+).
CONCLUSIONS: Dramatic changes in age distributions of prostate cancer incidence, mortality and hospitalizations altered age profiles of men with prostate cancer. This illustrated the changing nature of prostate cancer as a public health issue and has important implications for health care provision, e.g., the increased numbers of younger new patients have different needs from the increasing numbers of elderly long-term patients who now spend less time in hospital.

Entities:  

Mesh:

Year:  2007        PMID: 17278680      PMCID: PMC6976190     

Source DB:  PubMed          Journal:  Can J Public Health        ISSN: 0008-4263


  17 in total

1.  Prevalence-corrected prostate cancer incidence rates and trends.

Authors:  Ray M Merrill; Mark K Morris
Journal:  Am J Epidemiol       Date:  2002-01-15       Impact factor: 4.897

Review 2.  Prostate cancer: screening and early detection.

Authors:  M M Cookson
Journal:  Cancer Control       Date:  2001 Mar-Apr       Impact factor: 3.302

3.  International trends and patterns of prostate cancer incidence and mortality.

Authors:  A W Hsing; L Tsao; S S Devesa
Journal:  Int J Cancer       Date:  2000-01-01       Impact factor: 7.396

4.  Trends in prostate cancer incidence, hospital utilization and surgical procedures, Canada, 1981-2000.

Authors:  C Ineke Neutel; Ru-Nie Gao; Paul A Blood; Leslie A Gaudette
Journal:  Can J Public Health       Date:  2006 May-Jun

5.  Cancer statistics, 2001.

Authors:  R T Greenlee; M B Hill-Harmon; T Murray; M Thun
Journal:  CA Cancer J Clin       Date:  2001 Jan-Feb       Impact factor: 508.702

6.  Prostate carcinoma incidence and patient mortality: the effects of screening and early detection.

Authors:  O W Brawley
Journal:  Cancer       Date:  1997-11-01       Impact factor: 6.860

7.  A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer.

Authors:  Lars Holmberg; Anna Bill-Axelson; Fred Helgesen; Jaakko O Salo; Per Folmerz; Michael Häggman; Swen-Olof Andersson; Anders Spångberg; Christer Busch; Steg Nordling; Juni Palmgren; Hans-Olov Adami; Jan-Erik Johansson; Bo Johan Norlén
Journal:  N Engl J Med       Date:  2002-09-12       Impact factor: 91.245

8.  Modeling the impact of the decline in distant stage disease on prostate carcinoma mortality rates.

Authors:  Eric J Feuer; Angela Mariotto; Ray Merrill
Journal:  Cancer       Date:  2002-08-15       Impact factor: 6.860

9.  Prostate cancer incidence and mortality rates and trends in the United States and Canada.

Authors:  Kathleen McDavid; Judy Lee; John P Fulton; Jon Tonita; Trevor D Thompson
Journal:  Public Health Rep       Date:  2004 Mar-Apr       Impact factor: 2.792

10.  Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer.

Authors:  P C Albertsen; J A Hanley; D F Gleason; M J Barry
Journal:  JAMA       Date:  1998-09-16       Impact factor: 56.272

View more
  4 in total

1.  Guideline for optimization of surgical and pathological quality performance for radical prostatectomy in prostate cancer management: evidentiary base.

Authors:  Joseph L Chin; John Srigley; Linda A Mayhew; R Bryan Rumble; Claire Crossley; Amber Hunter; Neil Fleshner; Bish Bora; Robin McLeod; Sheila McNair; Bernard Langer; Andrew Evans
Journal:  Can Urol Assoc J       Date:  2010-02       Impact factor: 1.862

Review 2.  Targeting the androgenic pathway in elderly patients with castration-resistant prostate cancer: A meta-analysis of randomized trials.

Authors:  Giandomenico Roviello; Maria Rosa Cappelletti; Laura Zanotti; Angela Gobbi; Chiara Senti; Alberto Bottini; Andrea Ravelli; Alberto Bonetta; Giovanni Paganini; Daniele Generali
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

3.  Global incidence of prostate cancer in developing and developed countries with changing age structures.

Authors:  Jeremy Y C Teoh; Hoyee W Hirai; Jason M W Ho; Felix C H Chan; Kelvin K F Tsoi; Chi Fai Ng
Journal:  PLoS One       Date:  2019-10-24       Impact factor: 3.240

4.  Incidence and Mortality of Prostate Cancer in Canada during 1992-2010.

Authors:  François Lagacé; Feras M Ghazawi; Michelle Le; Evgeny Savin; Andrei Zubarev; Mathieu Powell; Linda Moreau; Denis Sasseville; Ioana Popa; Ivan V Litvinov
Journal:  Curr Oncol       Date:  2021-02-21       Impact factor: 3.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.